ITT (ITT) - 2025 Q4 - Earnings Call Transcript

Financial Data and Key Metrics Changes - Revenue grew by 8% in total and 5% organically for 2025, with EPS increasing by 14% or 18% when excluding certain impacts [7][19] - Operating income rose by 11%, and operating margin expanded by 40 basis points to 18.2% [7] - Free cash flow increased to over $550 million, up 27%, with a free cash flow margin of 14% [9][18] Business Line Data and Key Metrics Changes - In Q4, orders and revenue both exceeded $1 billion for the first time, with orders growing by 15% or 9% organically [8] - CCT saw an outstanding 40% organic growth, with contributions from both legacy business and kSARIA [8][17] - IP segment grew significantly, with Svanehøj increasing over 50% and legacy pump projects up 30% organically [17] Market Data and Key Metrics Changes - Backlog ended at $1.9 billion, up 18% year-over-year, indicating strong future demand [9] - Aerospace and defense sectors contributed significantly to growth, with CCT orders up 27% and 17% respectively [17] - The automotive market showed mixed signals, with expectations for flat to low single-digit growth in 2026 [49] Company Strategy and Development Direction - The company is focused on organic growth and M&A, with the pending acquisition of SPX FLOW expected to accelerate growth in higher margin flow business [10][26] - Investments in new products and technologies, such as VIDAR in flow and high-performance friction materials, are aimed at capturing previously unaddressed markets [10][12] - The company aims to leverage synergies from acquisitions while maintaining operational stability in existing businesses [68] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the 2026 outlook, expecting total revenue growth of approximately 11% and 5% organically [24] - The aerospace recovery is expected to drive growth, with significant contributions from aftermarket sales [48] - Management noted that while some cyclical improvements are observed, it is still early to determine the overall market trajectory [79] Other Important Information - The company completed an equity raise in December to fund the SPX FLOW acquisition, which is expected to close in March [5][26] - Significant progress was made in operational performance, with improvements in safety, quality, delivery, and cost metrics [20] Q&A Session Summary Question: Update on IP orders and funnel visibility - Management indicated that the funnel is stable compared to Q3, with growth in the Middle East and Asia Pacific [34][35] Question: Clarification on CCT's 40% organic growth - Management noted that the growth was broad-based, with connectors and controls seeing significant increases, and only minor price adjustments affecting the results [37] Question: Sustainability of SPX FLOW's order trajectory - Management expressed confidence in SPX FLOW's position in the nutrition and health segments, indicating a good CapEx cycle [46] Question: Changes in outlook for 2026 - Management confirmed that trends in aerospace and defense are strengthening, while the automotive market is expected to remain flat [49] Question: Competitive behavior in IP - Management reported no significant changes in competitive behavior, with improved performance leading to customer loyalty [92] Question: Incremental opportunities in biopharma valves - Management highlighted significant growth in the GLP-1 business and ongoing expansion opportunities in Europe [95]